Goa Pharma Summit Discusses India Pharma Inc's Trajectory As A Global Supply Destination

Under the theme,‘Unlocking India Pharma Inc’s true potential, experts share their success story and discuss the way forward on making Goa an ideal pharma hub

- 

EXPRESS PHARMA, in association with Goa Pharmaceutical Manufacturer's Association (GPMA), recently organised the Goa Pharma Summit. The theme for the summit was ‘Unlocking India Pharma Inc’s true potential’. The event was attended by more than 70 delegates from the pharma industry who have their base in Goa. Speakers emphasised on the advantages and opportunities which the state beholds for pharma companies.

Experts and veterans of the industry addressed critical issues such as Building on India's cost advantage; Innovation strategies for the next decade; Leveraging technology to future-proof key processes; Learning from international best practices; Embracing digital for accelerated growth; Exploring strategic alliances to enter newer markets; Building stronger quality systems for improved compliance; Tackling price controls and protectionism and Evolving regulatory landscape.

The conference began with a lamp lighting ceremony by Jyoti Sardesai, Director, Goa FDA, who was also the Chief Guest, and Mahesh Gurnasinghani, Secretary, GPMA. In the Chief Guest’s address, Sardesai highlighted that regulatory compliance in the state and informed that pharma products manufactured in Goa have crossed the 10,000-crore mark, thanks to its conducive business environment.

The first speaker of the event, Gurnasinghani shared GPMA’s Vision and Mission to make Goa a major supply destination. He spoke on various advantages which the state offers such as great connectivity, good talent, a conducive business environment, and others for the pharma sector.

He also mentioned that Goa is upgrading many facilities and measures are being undertaken to provide more value to the players such as improving its logistics chain, upskilling the resources and building more capacities and others.”